T2 Biosystems Inc (TTOO)
0.79
-0.01
(-1.25%)
USD |
NASDAQ |
Nov 05, 16:00
0.80
+0.01
(+1.27%)
After-Hours: 19:07
T2 Biosystems Debt to Equity Ratio: -1.998 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -1.998 |
| March 31, 2024 | -1.103 |
| December 31, 2023 | -1.472 |
| September 30, 2023 | -2.127 |
| June 30, 2023 | -1.388 |
| March 31, 2023 | -1.004 |
| December 31, 2022 | -1.252 |
| September 30, 2022 | -1.553 |
| June 30, 2022 | -1.298 |
| March 31, 2022 | -1.881 |
| December 31, 2021 | -3.704 |
| September 30, 2021 | -19.14 |
| June 30, 2021 | 5.160 |
| March 31, 2021 | -81.02 |
| December 31, 2020 | 5.184 |
| September 30, 2020 | 2.538 |
| June 30, 2020 | -10.03 |
| March 31, 2020 | -5.639 |
| December 31, 2019 | -1.262 |
| September 30, 2019 | -1.631 |
| June 30, 2019 | -2.746 |
| March 31, 2019 | -26.87 |
| Date | Value |
|---|---|
| December 31, 2018 | 3.721 |
| September 30, 2018 | 1.779 |
| June 30, 2018 | 1.317 |
| March 31, 2018 | -4.155 |
| December 31, 2017 | 31.12 |
| September 30, 2017 | 2.290 |
| June 30, 2017 | 3.349 |
| March 31, 2017 | 1.578 |
| December 31, 2016 | 1.036 |
| September 30, 2016 | 0.6473 |
| June 30, 2016 | 1.536 |
| March 31, 2016 | 0.8696 |
| December 31, 2015 | 0.6513 |
| September 30, 2015 | 0.8719 |
| June 30, 2015 | 0.6116 |
| March 31, 2015 | 0.4805 |
| December 31, 2014 | 0.3954 |
| September 30, 2014 | 0.1794 |
| June 30, 2014 | -0.0391 |
| March 31, 2014 | 0.6371 |
| December 31, 2013 | -0.0565 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-81.02
Minimum
Mar 2021
5.184
Maximum
Dec 2020
-6.473
Average
-1.472
Median
Dec 2023
Debt to Equity Ratio Benchmarks
| Boston Scientific Corp | 0.5254 |
| Hologic Inc | 0.5137 |
| Ekso Bionics Holdings Inc | 0.3602 |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 21.72M |
| Total Liabilities (Quarterly) | 27.62M |
| Shareholders Equity (Quarterly) | -5.898M |
| Current Ratio | 0.5962 |
| Net Debt Paydown Yield | 8.25% |